FDA
-
-
-
-
-
-
-
Theralase(R) Closes C$4.8 Million Offering
-
-
-
-
-
-
-
Theralase(R) Provides Update on Bladder Cancer Clinical Study
-
-
-
-
-
-
-
Ruvidar Demonstrates 7 Year Complete Response
-
-
-
-
-
-
-
Theralase(R) Provides Update on Bladder Cancer Clinical Study
-
-
-
-
-
-
-
Theralase Releaseās 3Q2023 Interim Financial Statements
-
-
-
-
-
-
-
TheralaseĀ® Releases FY2022 Audited Financial Statements
-
-
-
-
-
-
-
Theralase Releases Q12021 Interim Financial Statements
-
336,910 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


